100mg.pdf · created date: 9/25/2020 11:59:02 am

2
od I Haripur Subject: AUI a rt o ! b F. No.03-3412020-QC Government of Pakistan Drug Regulatory Authority of Pakistan Ministry of National Health Services, Regulation & Coordination *>ls**:k{.**;1.* MOST IMMEDIATE THROUGH COURRIER lslamabad, the 25th Septernber, 2020 [Medical Product Alert] "Redzi 100mg Solution for Injection" (Remdesivir Smg/ml) M/s Wnsfeild Pharmaceuticals, Plot No. 122, Block-A, Phase-V Hattar Industrial Estate, DRUG RECALL OF SUBSTANDARD REDZI IOOMG SOLUTION FOR INFUSION. REG. NO. 103I79. BA TCH NO. LV-004, MFG. DATE 07- 2020. EXP. DATE 07-2021 MA ACTURED BY M/S WNSFEILD PHARMACET S. HATTAR. I am directed to refer to the subject cited above and CDL, Karachi report vide No.KQ.l8912020 dated 28th July,2020 wherein your product "Redzi l00mg Solution for lnfusion (Remdesivir 5mg/ml)", Reg. No.103179, Batch No.LV-004, Mfg. Date 07-2020, Exp. Date 07-2021has been declared of Substandard quality. Details of CDL repofts are as under; 02. You are therefore directed to recall all the stock of above-mentioned batch of product "Redzi l00mg Solution for Infusion" from market, alert your sales officers/suppliers/ distributors to issue instructions to the pharmacies/hospitals, point of sales/purchase/use for the return of suspected stocks of product in question. Furthermore, you are directed to submit a compliance report of recall to this division within seven (07) days positively. S.No. test Specifications Result Reference I 2 J 4 5 6 Description ldentification pH determined Bacterial Sterility test Endotoxin test Assay Remdesivir (labelclaim 5mg/ml) Clear colorless solution in clear glass vial. Remdesivir identified 3.0 -4.0 Non-sterile Not more than L0 EU per mg 90.0% - l10.0% Complies Complies Complies Does not comply Complies 95.1% Innovator Specs Innovator Specs. Innovator Specs. USP 42 USP 42 Innovator Specs

Upload: others

Post on 27-Sep-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: 100mg.pdf · Created Date: 9/25/2020 11:59:02 AM

od I

Haripur

Subject:

AUI

art

o

!

b

F. No.03-3412020-QCGovernment of Pakistan

Drug Regulatory Authority of PakistanMinistry of National Health Services,

Regulation & Coordination*>ls**:k{.**;1.*

MOST IMMEDIATETHROUGH COURRIER

lslamabad, the 25th Septernber, 2020

[Medical Product Alert]

"Redzi 100mg Solution for Injection"

(Remdesivir Smg/ml)

M/s Wnsfeild Pharmaceuticals,

Plot No. 122, Block-A, Phase-V

Hattar Industrial Estate,

DRUG RECALL OF SUBSTANDARD REDZI IOOMG SOLUTION FOR

INFUSION. REG. NO. 103I79. BATCH NO. LV-004, MFG. DATE 07-

2020. EXP. DATE 07-2021 MA ACTURED BY M/S WNSFEILD

PHARMACET S. HATTAR.

I am directed to refer to the subject cited above and CDL, Karachi report vide

No.KQ.l8912020 dated 28th July,2020 wherein your product "Redzi l00mg Solution for

lnfusion (Remdesivir 5mg/ml)", Reg. No.103179, Batch No.LV-004, Mfg. Date 07-2020,

Exp. Date 07-2021has been declared of Substandard quality. Details of CDL repofts are as

under;

02. You are therefore directed to recall all the stock of above-mentioned batch of product

"Redzi l00mg Solution for Infusion" from market, alert your sales officers/suppliers/

distributors to issue instructions to the pharmacies/hospitals, point of sales/purchase/use for

the return of suspected stocks of product in question. Furthermore, you are directed to submit

a compliance report of recall to this division within seven (07) days positively.

S.No. test Specifications Result ReferenceI

2

J

4

5

6

Description

ldentificationpH determinedBacterial SterilitytestEndotoxin testAssayRemdesivir(labelclaim 5mg/ml)

Clear colorless solution inclear glass vial.Remdesivir identified3.0 -4.0Non-sterile

Not more than L0 EU permg90.0% - l10.0%

Complies

CompliesCompliesDoes notcomplyComplies

95.1%

Innovator Specs

Innovator Specs.

Innovator Specs.USP 42

USP 42

Innovator Specs

Page 2: 100mg.pdf · Created Date: 9/25/2020 11:59:02 AM

-/sd-(Shahid Nawaz)

Assistant Director (QC-ID

Copv for information and necessary action - with request to issue necessary directions topoints of use/sale (Hospitals Pharmacies. Medical stores. Distributors, Whole sellers. etc)under administrative control/ fall under area of iurisdiction. please.

L The Secretary (SHC&ME) Health Department (Government of Punjab).2. The Secretary Primary and Secondary Health Department (Government of Punjab).3. The Secretary Health Department (Government of Sindh).4. The Secretary (SHC&ME) Health Department (Govemment of KPK).5. The Secretary (SHC&ME) Health Department (Government of Baluchistan).6. The Secretary (SHC&ME) Health Department (Government of AJ&K).7. The Director General Health, M/o NHSR&C, Islamabad.8. The Director General Health, Government of Punjab.9. The Director General Health, Government of Sindh.10. The Director General Health, Government of KPK.I l. The Director General Health, Government of Baluchistan.12. The Director General Health, Government of AJ&K.l3.The Additional Director / Office ln-charge, DRAP, Lahore, Karachi, Islamabad,

Peshawar, and Quetta.14. The Chief Drug Controller / Inspector Punjab, Sindh, KPK, Baluchistan, AJ&K, GB and

ICT.

Copy to:-r The Director, QA&LT, DRAP, Islamabad.The Additional Director MIS with request to upload it on official website in the largerinterest of public.FID-V, DRAP, Karachi for information record and necessary action, if any, please.

PS to CEO, DRAP, lslamabad.Office copy.

(Assistan? rector QC-ID

lllIV

-c{,-ro)r)